Dysregulation of FMRP/mTOR Signaling Cascade in Hypoxic-Ischemic Injury of Premature Human Brain

J Child Neurol. 2016 Mar;31(4):426-32. doi: 10.1177/0883073815596617. Epub 2015 Aug 3.

Abstract

In this study the authors investigated whether dysregulation of the fragile X mental retardation protein and mammalian target of rapamycin signaling cascade can have a role in the pathogenesis of encephalopathy of prematurity following perinatal hypoxia-ischemia. The authors examined the brain tissue of newborns with encephalopathy and compared it to age-matched controls with normal brain development and adults. In normal controls, the fragile X mental retardation protein expression in cortical gray matter spiked 4-fold during 36-39 gestational weeks compared to the adult, with a concomitant suppression of p70S6K and S6. In encephalopathy cases, the developmental spike of fragile X mental retardation protein was not observed, and fragile X mental retardation protein levels remained significantly lower than in normal controls. Importantly, this fragile X mental retardation protein downregulation was followed by a significant overexpression of p70S6K and S6. These novel findings thus suggest that premature hypoxic-ischemic brain injury can affect the fragile X mental retardation protein/mammalian target of rapamycin pathway, as otherwise observed in inherited syndromes of cognitive disability and autism spectrum disorders.

Keywords: autism; brain injury; fragile X mental retardation protein; hypoxia; mammalian target of rapamycin; prematurity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Brain / growth & development
  • Brain / metabolism*
  • Brain / pathology
  • Female
  • Fragile X Mental Retardation Protein / metabolism*
  • Humans
  • Hypoxia-Ischemia, Brain / metabolism*
  • Hypoxia-Ischemia, Brain / pathology
  • Immunohistochemistry
  • Infant, Newborn
  • Male
  • Middle Aged
  • Pilot Projects
  • Signal Transduction
  • TOR Serine-Threonine Kinases / metabolism*

Substances

  • FMR1 protein, human
  • Fragile X Mental Retardation Protein
  • MTOR protein, human
  • TOR Serine-Threonine Kinases